Related references
Note: Only part of the references are listed.RNA-sequence-based microRNA expression signature in breast cancer: tumor-suppressive miR-101-5p regulates molecular pathogenesis
Hiroko Toda et al.
MOLECULAR ONCOLOGY (2020)
MicroRNA-99a Suppresses Breast Cancer Progression by Targeting FGFR3
Xinghua Long et al.
FRONTIERS IN ONCOLOGY (2020)
Cell-free miRNAs as non-invasive biomarkers in breast cancer: Significance in early diagnosis and metastasis prediction
Dharambir Kashyap et al.
LIFE SCIENCES (2020)
Cancer treatment and survivorship statistics, 2019
Kimberly D. Miller et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
miR-155, miR-96 and miR-99a as potential diagnostic and prognostic tools for the clinical management of hepatocellular carcinoma
Shufang Ning et al.
ONCOLOGY LETTERS (2019)
Circulating MicroRNAs as Biomarkers for Prostate Cancer Detection and Metastasis Development Prediction
David Bidarra et al.
FRONTIERS IN ONCOLOGY (2019)
The Regulatory Role of MicroRNAs in Breast Cancer
Hui-Yi Loh et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Circulating miRNAs as Diagnostic and Prognostic Biomarkers in Common Solid Tumors: Focus on Lung, Breast, Prostate Cancers, and Osteosarcoma
Michela Bottani et al.
JOURNAL OF CLINICAL MEDICINE (2019)
MicroRNA-99a-5p suppresses breast cancer progression and cell-cycle pathway through downregulating CDC25A
Hongzhen Qin et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Overexpression of circulating MiR-30b-5p identifies advanced breast cancer
Helena Estevao-Pereira et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2019)
The miRNA-449 family mediates doxorubicin resistance in triple-negative breast cancer by regulating cell cycle factors
Eduardo Tormo et al.
SCIENTIFIC REPORTS (2019)
Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer
Minghui Li et al.
BREAST CANCER RESEARCH AND TREATMENT (2018)
Breast cancer diagnosis: Imaging techniques and biochemical markers
Seyed Hamed Jafari et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Identification and Validation of Circulating MicroRNA Signatures for Breast Cancer Early Detection Based on Large Scale Tissue-Derived Data
Xiaokang Yu et al.
JOURNAL OF BREAST CANCER (2018)
Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers
Rimi Hamam et al.
CELL DEATH & DISEASE (2017)
The role of miR-26a and miR-30b in HER2+breast cancer trastuzumab resistance and regulation of the CCNE2 gene
Eduardo Tormo et al.
SCIENTIFIC REPORTS (2017)
Low levels of serum miR-99a is a predictor of poor prognosis in breast cancer
J. Li et al.
GENETICS AND MOLECULAR RESEARCH (2016)
MiR-99a Inhibits Cell Proliferation and Tumorigenesis through Targeting mTOR in Human Anaplastic Thyroid Cancer
Hou-Gang Huang et al.
Asian Pacific Journal of Cancer Prevention (2015)
Circulating microRNAs as novel prognosis biomarkers for head and neck squamous cell carcinoma
Bo Hou et al.
CANCER BIOLOGY & THERAPY (2015)
Tumor MicroRNA Expression Profiling Identifies Circulating MicroRNAs for Early Breast Cancer Detection
Nerea Matamala et al.
CLINICAL CHEMISTRY (2015)
miRNA-99b-3p functions as a potential tumor suppressor by targeting glycogen synthase kinase-3β in oral squamous cell carcinoma Tca-8113 cells
Kang He et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
MicroRNA-99a inhibits tumor aggressive phenotypes through regulating HOXA1 in breast cancer cells
Xiaolong Wang et al.
ONCOTARGET (2015)
miR-99a Suppresses the Metastasis of Human Non-Small Cell Lung Cancer Cells by Targeting AKT1 Signaling Pathway
Shi-huan Yu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2015)
MiR-99a Antitumor Activity in Human Breast Cancer Cells through Targeting of mTOR Expression
Yu Hu et al.
PLOS ONE (2014)
microRNA-99a acts as a tumor suppressor and is down-regulated in bladder cancer
Yougang Feng et al.
BMC UROLOGY (2014)
Identification of Circulating MicroRNA Signatures for Breast Cancer Detection
Maurice Chan et al.
CLINICAL CANCER RESEARCH (2013)
Circulating microRNAs in plasma as early detection markers for breast cancer
Katarina Cuk et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Circulating microRNAs as Specific Biomarkers for Breast Cancer Detection
Enders K. O. Ng et al.
PLOS ONE (2013)
Deregulation of miR-100, miR-99a and miR-199b in tissues and plasma coexists with increased expression of mTOR kinase in endometrioid endometrial carcinoma
Anna Torres et al.
BMC CANCER (2012)
Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer
Niels H. H. Heegaard et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
MIR-99a and MIR-99b Modulate TGF-β Induced Epithelial to Mesenchymal Plasticity in Normal Murine Mammary Gland Cells
Gianluca Turcatel et al.
PLOS ONE (2012)
Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers
Eleni van Schooneveld et al.
BREAST CANCER RESEARCH (2012)
MicroRNA-99a Inhibits Hepatocellular Carcinoma Growth and Correlates with Prognosis of Patients with Hepatocellular Carcinoma
Dong Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Characterization of extracellular circulating microRNA
Andrey Turchinovich et al.
NUCLEIC ACIDS RESEARCH (2011)
Selective Release of MicroRNA Species from Normal and Malignant Mammary Epithelial Cells
Lucy Pigati et al.
PLOS ONE (2010)
Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening
E. K. O. Ng et al.
GUT (2009)
Down-Regulation of miR-92 in Human Plasma Is a Novel Marker for Acute Leukemia Patients
Masami Tanaka et al.
PLOS ONE (2009)
Circulating microRNAs as stable blood-based markers for cancer detection
Patrick S. Mitchell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
MicroRNA gene expression deregulation in human breast cancer
MV Iorio et al.
CANCER RESEARCH (2005)
Optimal cut-point and its corresponding youden index to discriminate individuals using pooled blood samples
EF Schisterman et al.
EPIDEMIOLOGY (2005)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Micrornas: Small RNAs with a big role in gene regulation
L He et al.
NATURE REVIEWS GENETICS (2004)
Share Paper
